Old Web
English
Sign In
Acemap
>
authorDetail
>
Joost C. Beusekamp
Joost C. Beusekamp
University Medical Center Groningen
Empagliflozin
Medicine
Internal medicine
Diuresis
Cardiology
3
Papers
108
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effects of SGLT2 inhibition with Empagliflozin on Potassium Handling in Patients with Acute Heart Failure
2021
European Journal of Heart Failure
Joost C. Beusekamp
Jasper Tromp
Eva M. Boorsma
Hiddo J.L. Heerspink
Kevin Damman
Adriaan A. Voors
Peter van der Meer
Show All
Source
Cite
Save
Citations (0)
Randomized, double‐blind, placebo‐controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA‐RESPONSE‐AHF)
2020
European Journal of Heart Failure
Kevin Damman
Joost C. Beusekamp
Eva M. Boorsma
Henk P Swart
Tom D.J. Smilde
Arif Elvan
J.W. Martijn van Eck
Hiddo J.L. Heerspink
Adriaan A. Voors
Show All
Source
Cite
Save
Citations (94)
Effects of Empagliflozin on Renal Sodium and Glucose Handling in Patients with Acute Heart Failure.
2020
European Journal of Heart Failure
Eva M. Boorsma
Joost C. Beusekamp
Jozine M. ter Maaten
Sylwia M. Figarska
A.H. Jan Danser
Dirk J. van Veldhuisen
Peter van der Meer
Hiddo J.L. Heerspink
Kevin Damman
Adriaan A. Voors
Show All
Source
Cite
Save
Citations (14)
1